D-0925-2019 Class I Terminated

Recalled by King Bio Inc. — Asheville, NC

FDA drug recall D-0925-2019 was initiated by King Bio Inc. on Jul 20, 2018 and is designated Class I. Reason for recall: Microbial contamination The recall status is terminated (terminated Jan 19, 2022). Affected quantity: 6400 bottles.

Recall Details

Product Type
Drugs
Report Date
Mar 20, 2019
Initiation Date
Jul 20, 2018
Termination Date
Jan 19, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6400 bottles

Product Description

NET Remedies #9 Homeopathic Preparation, Oral Liquid, 57 mL, Manufacturer: King Bio Inc. U.S.A., Supplier: NET (Australia) Pty LTD 428 Hume Street, Toowoomba QLD 4350, Australia

Reason for Recall

Microbial contamination

Distribution Pattern

U.S.A. Nationwide, Canada, and Australia.

Code Information

Lots: AUS-011117G Exp. 01/20; AUS-011916J Exp. 01/19; AUS-030816J Exp. 03/19; AUS-030917C Exp. 03/20; AUS-050516H Exp. 05/19; AUS-081516B Exp. 08/19; AUS-091515H Exp. 09/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0925-2019
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.